Entropy of left ventricular late gadolinium enhancement and its prognostic value in hypertrophic cardiomyopathy a new CMR assessment method

被引:5
作者
Zhao, Xiaoying [1 ]
Jin, Fuwei [1 ]
Wang, Jin [2 ]
Zhao, Xinxiang [1 ]
Wang, Lujing [1 ]
Wei, Hua [3 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 2, Dept Radiol, Dianmiandadao 374, Kunming 650000, Yunnan, Peoples R China
[2] Yanan Hosp Kunming City, Dept Radiol, Renmin Dong Lu 245, Kunming 650000, Yunnan, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 2, Dept Informat, Dianmiandadao 374, Kunming 650000, Yunnan, Peoples R China
关键词
Cardiac magnetic resonance; Hypertrophic cardiomyopathy; Risk stratification; INDEX; PREDICTION;
D O I
10.1016/j.ijcard.2022.11.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: As a novel metric, entropy generated from late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) can be utilized to assess tissue heterogeneity. However, it is unknown if it can be utilized for risk stratification in hypertrophic cardiomyopathy (HCM). In addition, it is unknown if LGE entropy correlates with LGE mass%, which is commonly utilized for fibrosis assessment. This research was done to investigate these issues. Materials and methods: Patients with HCM who underwent 3.0-T CMR between January 2015 and January 2020 were prospectively enrolled and classified into low-and high-risk groups according to the AHA/ACC risk stratification guideline for 2020. The LGE entropy was automatically estimated using a generic Python package algorithm. On CMR imaging, the LGE mass% was determined using the CVI 42 software. Endpoint events included sudden cardiac death (SCD), hospital readmission owing to heart failure, and implantable cardioverter defibrillator (ICD) treatment for ventricular arrhythmias.Results: A total of 109 HCM participants (70 males) were included. During the follow-up (23 +/- 7 months), the patients in the high-risk group had higher LGE entropy (p < 0.001) and LGE mass% (p < 0.001) than those in the low-risk group, and patients with endpoint events had higher LGE entropy (p < 0.001) and LGE mass% (p < 0.001) than those without endpoint events. In all participants, there was a link between LGE entropy and LGE mass%, according to the Spearman rank correlation analysis (p < 0.001; r = 0.667). In ROC analysis, the area under the curve (AUC) of LGE entropy was 0.893 (95% CI, 0.794-0.993; P<0.001), AUC of LGE mass% was 0.826 (95% CI, 0.737-0.914; P<0.001), AUC of LVEF was 0.610 (95% CI, 0.473-0.748; P = 0.117) and AUC of 2020 AHA/ACC guideline for risk stratification was 0.716 (95% CI, 0.617-0.815; P = 0.002). According to Kaplan-Meier curves, HCM with a higher LGE entropy (>= cutoff value (<5.873) or >= thied tertile (5.540)) were more likely to experience the endpoint events. Following adjustment for the 2020 AHA/ACC guideline for risk categorization, LGE mass%, or decreased LVEF, Cox analysis showed that LGE entropy was independently linked with endpoint events.Conclusions: The variability and extent of LGE pictures can be reflected by LGE entropy, which is a reliable, usable, and repeatable metric for risk classification in HCM. It is a prognostic indicator of endpoint events that is independent of other risk indicators.
引用
收藏
页码:134 / 141
页数:8
相关论文
共 34 条
  • [1] Association between reduced myocardial contraction fraction and cardiovascular disease outcomes: The Multi-Ethnic Study of Atherosclerosis
    Abdalla, Marwah
    Akwo, Elvis A.
    Bluemke, David A.
    Lima, Joao A. C.
    Shimbo, Daichi
    Maurer, Mathew S.
    Bertoni, Alain G.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 293 : 10 - 16
  • [2] Comparison of Bispectral Index and Entropy values with electroencephalogram during surgical anaesthesia with sevoflurane
    Aho, A. J.
    Kamata, K.
    Jantti, V.
    Kulkas, A.
    Hagihira, S.
    Huhtala, H.
    Yli-Hankala, A.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2015, 115 (02) : 258 - 266
  • [3] Entropy as a Novel Measure of Myocardial Tissue Heterogeneity for Prediction of Ventricular Arrhythmias and Mortality in Post-Infarct Patients
    Androulakis, Alexander F. A.
    Zeppenfeld, Katja
    Paiman, Elisabeth H. M.
    Piers, Sebastiaan R. D.
    Wijnmaalen, Adrianus P.
    Siebelink, Hans-Marc J.
    Sramko, Marek
    Lamb, Hildo J.
    van der Geest, Rob J.
    de Riva, Marta
    Tao, Qian
    [J]. JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (04) : 480 - 489
  • [4] Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias
    Ariga, Rina
    Tunnicliffe, Elizabeth M.
    Manohar, Sanjay G.
    Mahmod, Masliza
    Raman, Betty
    Piechnik, Stefan K.
    Francis, Jane M.
    Robson, Matthew D.
    Neubauer, Stefan
    Watkins, Hugh
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (20) : 2493 - 2502
  • [5] Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management
    Baxi, Ameya Jagdish
    Restrepo, Carlos S.
    Vargas, Daniel
    Marmol-Velez, Alejandro
    Ocazionez, Daniel
    Murillo, Horacio
    [J]. RADIOGRAPHICS, 2016, 36 (02) : 335 - 354
  • [6] Entropy-based analysis for diffusion anisotropy mapping of healthy and myelopathic spinal cord
    Cui, Jiao-Long
    Wen, Chun-Yi
    Hu, Yong
    Li, Ting-Hung
    Luk, Keith Dip-Kei
    [J]. NEUROIMAGE, 2011, 54 (03) : 2125 - 2131
  • [7] Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteria
    Desai, Milind Y.
    Smedira, Nicholas G.
    Dhillon, Ashwat
    Masri, Ahmad
    Wazni, Oussama
    Kanj, Mohamad
    Sato, Kimi
    Thamilarasan, Maran
    Popovic, Zoran B.
    Lever, Harry M.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (02) : 750 - +
  • [8] Prognostic value of SPECT myocardial perfusion entropy in high-risk type 2 diabetic patients
    Djaileb, Loic
    Seiller, Alexandre
    Canu, Marjorie
    De Leiris, Nicolas
    Martin, Alix
    Poujol, Julie
    Fraguas-Rubio, Alicia
    Leenhardt, Julien
    Carabelli, Adrien
    Calizzano, Alex
    De Fondaumiere, Marie
    Broisat, Alexis
    Desvignes, Michel
    Vanzetto, Gerald
    Ghezzi, Catherine
    Fagret, Daniel
    Riou, Laurent M.
    Barone-Rochette, Gilles
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (06) : 1813 - 1821
  • [9] Visual estimation of the extent of myocardial hyperenhancement on late gadolinium-enhanced CMR in patients with hypertrophic cardiomyopathy
    Doesch, Christina
    Huck, Sonia
    Boehm, Christoph K.
    Michaely, Henrik
    Fluechter, Stephan
    Haghi, Dariusch
    Dinter, Dietmar
    Borggrefe, Martin
    Papavassiliu, Theano
    [J]. MAGNETIC RESONANCE IMAGING, 2010, 28 (06) : 812 - 819
  • [10] Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
    Elliott, Perry
    Andersson, Bert
    Arbustini, Eloisa
    Bilinska, Zofia
    Cecchi, Franco
    Charron, Philippe
    Dubourg, Olivier
    Hl, Uwe Ku R.
    Maisch, Bernhard
    McKenna, William J.
    Monserrat, Lorenzo
    Pankuweit, Sabine
    Rapezzi, Claudio
    Seferovic, Petar
    Tavazzi, Luigi
    Keren, Andre
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 (02) : 270 - 276